Cantuzumab ravtansine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cantuzumab ravtansine?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target MUC1
Identifiers
CAS Registry Number 868747-45-9 N
ATC code None
 N (what is this?)  (verify)

Cantuzumab ravtansine (huC242-SPDB-DM4) is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody cantuzumab (huC242) is linked to a cytotoxic agent, ravtansine (DM4).[1] It uses a more hindered disulphide linkage than Cantuzumab mertansine.[2]

See also[edit]

References[edit]

  1. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information 25 (2). 
  2. ^ Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to ...